SEC 13F Intelligence

Sfe Investment Counsel / ABT

Sfe Investment Counsel’s Abbott Laboratories Position

Does Sfe Investment Counsel own Abbott Laboratories (ABT)? Yes — 81.7K shares worth $8M (+1.32% of its 13F portfolio) as of Q1 2026, up from 76.5K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
81.7K
% of Portfolio
+1.32%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $7MQ2 ’19: $7MQ3 ’19: $7MQ4 ’19: $7MQ4 ’19Q1 ’20: $4MQ2 ’20: $5MQ3 ’20: $6MQ4 ’20: $6MQ4 ’20Q1 ’21: $7MQ2 ’21: $7MQ3 ’21: $7MQ4 ’21: $8MQ4 ’21Q1 ’22: $7MQ2 ’22: $6MQ3 ’22: $6MQ4 ’22: $7MQ4 ’22Q1 ’23: $6MQ2 ’23: $6MQ3 ’23: $6MQ4 ’23: $6MQ4 ’23Q1 ’24: $7MQ2 ’24: $7MQ3 ’24: $8MQ4 ’24: $8MQ4 ’24Q1 ’25: $10MQ2 ’25: $11MQ3 ’25: $11MQ4 ’25: $10MQ4 ’25Q1 ’26: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202681.7K$8M+1.32%
Q4 202576.5K$10M+1.47%
Q3 202580.0K$11M+1.71%
Q2 202580.1K$11M+1.92%
Q1 202575.5K$10M+2.00%
Q4 202474.4K$8M+1.79%
Q3 202472.3K$8M+1.72%
Q2 202469.9K$7M+1.61%
Q1 202463.9K$7M+1.65%
Q4 202358.8K$6M+1.68%
Q3 202358.3K$6M+1.64%
Q2 202358.3K$6M+1.80%
Q1 202358.1K$6M+2.00%
Q4 202258.2K$7M+2.02%
Q3 202257.8K$6M+1.76%
Q2 202257.5K$6M+1.86%
Q1 202256.0K$7M+1.68%
Q4 202156.5K$8M+2.04%
Q3 202156.0K$7M+1.85%
Q2 202156.8K$7M+1.81%
Q1 202155.9K$7M+1.95%
Q4 202056.1K$6M+1.95%
Q3 202052.0K$6M+2.26%
Q2 202053.8K$5M+2.17%
Q1 202056.8K$4M+2.46%
Q4 201979.6K$7M+2.83%
Q3 201980.3K$7M+2.84%
Q2 201986.1K$7M+3.10%
Q1 201988.5K$7M+3.19%
Q4 201898.1K$7M+3.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sfe Investment Counsel’s full portfolio or all institutional holders of ABT.